The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Perspective
PreviousPrevious
Volume 352:1290-1292 March 31, 2005 Number 13
NextNext

Standards of Ethics at the National Institutes of Health
Robert Steinbrook, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
As of early February, the federal government has banned payments by drug companies to any employee of the National Institutes of Health (NIH) and has implemented broad restrictions on employees' outside activities and financial arrangements, including the holding of stock in biotechnology and pharmaceutical companies and the acceptance of prizes (see box).1 In addition, the NIH is reviewing its conflict-of-interest rules for the thousands of outside experts who provide advice to the agency each year — for example, through service on advisory committees, data and safety monitoring boards for clinical trials, and consensus-development panels. And Dr. Elias Zerhouni, the . . . [Full Text of this Article]


Source Information

Dr. Steinbrook is a national correspondent for the Journal.



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.